Skip to main content
Clinical Trials/IRCT2016100730187N1
IRCT2016100730187N1Completed未知

The effect of melatonin on pediateric drug resistant epilepcy

Mashhad University of Medical Sciences0 sites32 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
32

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
1 year to 15 years (—)
Sex
All

Inclusion Criteria

  • age in pediatrics' range between 1 to 15 years old; failure of at least 3 different antiepileptic drugs to control seizures; therapeutic stability for at least 1 month prior to the study, and 4 seizures or more in the last month prior to the initiation of the study.
  • Exclusion criteria: history of neurodegenerative disorders syndromes,
  • cardiovascular anomalies, liver and kidney dysfunction; history of pseudo seizures, seizures with so large numbers and variety that were uncountable; history of status or progressive seizure attack.

Exclusion Criteria

  • Not provided

Investigators

Similar Trials

The effect of melatonin on pediateric drug... | Clinical Trial